Study finds cannabis-based drugs help alleviate side-effects post-chemo; AIIMS to research further
Team Udayavani, Nov 25, 2018, 12:37 PM IST
New Delhi: Cannabis leaves have been found effective in alleviating pain and other symptoms in cancer patients post chemotherapy and radiotherapy, according to a study conducted by an autonomous body under the ministry of AYUSH.
The pilot study was carried out by the Central Council For Research in Ayurvedic Sciences (CCRAS) in collaboration with the Gujarat Ayurved University, Jamnagar, on patients undergoing treatment at the Tata Memorial Hospital in Mumbai.
The aim of the proposed AIIMS study is to validate these cannabis leaves-based drugs in order to standardise and exploit the potential of alternative therapy in improving the quality of life for cancer patients, he said.
Also, research is underway at the CCRAS for developing drugs based on cannabis for other ailments, Dhiman said.
Meanwhile, research to develop cost-effective cannabis based drugs for treatment of pain in cancer, epilepsy and sickle cell anaemia is being conducted by Council of Scientific and Industrial Research – Indian Institute of Integrative Medicine (CSIR – IIIM) in collaboration with Bombay Hemp Company (BOHECO).
Cannabis is being cultivated at the Jammu-based IIIM research station which has obtained licence from the state government to grow it to study its medicinal properties so that drugs can be developed for Indian population.
Cannabis based formulations that have been approved in other countries are being imported for fast-tracking clinical approvals in India and also trials on animals are being conducted.
IIIM Director Ram Vishwakarma said they want to conduct clinical trials of the drugs on terminally ill patients at the Tata Memorial Hospital for cancer, at the AIIMS for epilepsy and Sickle Cell Institute Chhattisgarh (SCIC) for sickle cell anaemia.
Vishwakarma said they are in talks with the Drug Controller General of India’s office to acquire approval for conducting trials to see the utility of cannabis as medicine in India.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Anti-obesity class of drugs related with fewer post-surgery complications: Study
1.48 lakh new TB cases identified in first 30 days of 100-day intensified campaign: Nadda
HMPV: Centre asks states to increase surveillance for respiratory diseases
No need for panic, HMPV not as transmissible as Covid: Karnataka govt
HMPV cases: Karnataka Health Minister says no reason to panic
MUST WATCH
Latest Additions
Adani-ISKCON to start ‘Mahaprasad Seva’ in Maha Kumbh
Six surrendered naxals produced before NIA court
A milestone in biotechnology research: PM Modi unveils genome sequencing data of 10,000 Indians
Delhi Police arrests two sharpshooters of Nandu Gang from Bangalore
Freebies or better amenities, choice rests with citizens: Panagariya
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.